Expert Insights for Prioritizing Therapeutic Targets in Advanced NSCLC

Did you catch all of this week's top oncology news? Test your knowledge with OncLive's Weekly News Quiz.

Readers share their opinions on some of the most talked-about lung cancer abstracts they’re looking forward to seeing at ESMO 2026.

Readers share their opinions on some of the most talked-about gynecologic cancer abstracts they’re looking forward to seeing at ESMO 2026.

Gastrointestinal oncologists weigh HER2 testing practices, the order of HER2-directed therapies, and emerging agents for metastatic colorectal cancer.

The FDA has granted traditional approval to pembrolizumab for unresectable/metastatic TMB-H solid tumors.

The FDA granted fast track designation to SBE303 for locally advanced or metastatic urothelial cancer previously treated with enfortumab vedotin.

The oral PLK1 inhibitor onvansertib received FDA orphan drug designation in CMML.

Phase 1 data support continued investigation of roginolisib in advanced cancers, including metastatic uveal melanoma.